Case study · SaMD & clinical trials
Bringing software architecture, quality system, and regulatory pathway into a single technical picture — so a digital therapeutic could progress through clinical trials without the strands pulling apart.

A clinical-grade product had to satisfy trial protocol, regulatory expectations, and a real delivery timeline at once — while the science, software, and regulatory strands were being planned and managed largely in isolation.
Left unmanaged, that separation is exactly where the chain from scientific idea to deployable, regulated product tends to break.
The strands were worked as one technical picture rather than four separate workstreams:
Software and trial systems delivered to clinical standard, supporting the product’s progress through clinical trials — and contributing to successful Innovate UK grant applications to the company’s name.
Illustrative detail — specific figures and artefacts shared directly on request.
At a glance
A regulated digital therapeutic, delivered under live clinical-trial conditions.
Services drawn on
Disciplines bridged
Science · Software · Regulatory
Next case study
Platform architecture — Our Future Health →
emergentsystems.consulting@gmail.com · © 2026 Emergent Systems